← Back to headlines
Mark Zuckerberg Backs AI Startup for Parkinson's Disease Treatment
Mark Zuckerberg has invested in Cellular Intelligence, a startup that has partnered with Novo Nordisk to acquire rights for an experimental Parkinson's treatment. The company plans to leverage artificial intelligence to accelerate the development of a cure.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
